Skip to main content

CEPI to develop vaccine printing technology with biotech firm

Submitted by lsekela on March 1, 2019 - 10:33 AM

In a move to defeat the next pandemic, the CEPI (Coalition for Epidemic Preparedness Innovations) has reportedly signed an agreement with CureVac, a German biopharmaceutical firm. The duo plan to develop a vaccine printing technology, with an aim to produce shots against various diseases.

Content Source:

Healthcare Opportunity

Content Author:

Akshay Kedari

Tags: